Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

539
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
539
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

570
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
570
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

348
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
348
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

577
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
577
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

604
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
604
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

696
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
696

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Frequency and Outcomes of Reduced Dose Non-Vitamin K Antagonist Anticoagulants: Results From ORBIT-AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II).

Journal of the American Heart Association·2018
Same author

Utility of cardiac computed tomography scanning in the diagnosis and pre-operative evaluation of patients with infective endocarditis.

The international journal of cardiovascular imaging·2018
Same author

New-Onset Atrial Fibrillation After PCI or CABG for Left Main Disease: The EXCEL Trial.

Journal of the American College of Cardiology·2018
Same author

High Prevalence of Occult Heart Failure With Preserved Ejection Fraction Among Patients With Atrial Fibrillation and Dyspnea.

Circulation·2018
Same author

Outcomes in anticoagulated patients with atrial fibrillation and with mitral or aortic valve disease.

Heart (British Cardiac Society)·2018
Same author

The Evolving Face of Myocardial Reperfusion in Acute Coronary Syndromes: A Primer for the Internist.

Mayo Clinic proceedings·2018

Related Experiment Video

Updated: Feb 16, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

10.7K

Clinical, Radiographic, and Microbiologic Features of Infective Endocarditis in Patients With Hypertrophic

Jason R Sims1, Nandan S Anavekar2, Subir Bhatia1

  • 1Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.

The American Journal of Cardiology
|December 23, 2017
PubMed
Summary

Infective endocarditis (IE) in hypertrophic cardiomyopathy (HC) patients shows similar rates of aortic and mitral valve involvement, challenging previous assumptions. This study found a low one-year mortality rate of 7% in this patient group.

More Related Videos

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
12:24

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse

Published on: June 20, 2014

10.5K
An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level
06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

6.2K

Related Experiment Videos

Last Updated: Feb 16, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

10.7K
Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
12:24

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse

Published on: June 20, 2014

10.5K
An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level
06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

6.2K

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Cardiovascular Surgery

Background:

  • Infective endocarditis (IE) presents significant morbidity and mortality.
  • Hypertrophic cardiomyopathy (HC) is associated with increased IE risk, but data are limited.
  • Understanding IE in HC patients is crucial for risk stratification and management.

Purpose of the Study:

  • To define the clinical phenotype of infective endocarditis in patients with hypertrophic cardiomyopathy.
  • To investigate the patterns of valve involvement and outcomes in this specific patient cohort.
  • To challenge existing tenets regarding the association between HC and IE.

Main Methods:

  • Retrospective cohort study at a single tertiary care center.
  • Inclusion of 30 adult patients diagnosed with HC and IE between 2006 and 2016.
  • Analysis of valve involvement (aortic vs. mitral), embolic complications, surgical interventions, and mortality.

Main Results:

  • Similar rates of aortic (47%) and mitral (53%) valve involvement by IE were observed.
  • This pattern persisted even in patients with left-ventricular outflow tract obstruction.
  • Symptomatic embolic complications occurred in 33% of cases, and 37% underwent surgery.
  • One-year mortality was notably low at 7%.

Conclusions:

  • The largest single-center cohort of IE complicating HC reveals similar mitral and aortic valve involvement, irrespective of left ventricular outflow tract obstruction.
  • This finding contradicts long-standing beliefs about HC and IE associations.
  • No specific IE subset at high risk was identified based on HC-related parameters.